Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis
- First Posted Date
- 2021-11-16
- Last Posted Date
- 2022-05-13
- Lead Sponsor
- TLL Pharmaceutical, LLC
- Registration Number
- NCT05121402
- Locations
- 🇺🇸
Gastroenterology Research of San Antonio (GERSA), San Antonio, Texas, United States
A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: TLL018 tablet, placebo
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2021-03-30
- Lead Sponsor
- TLL Pharmaceutical, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT04243083
- Locations
- 🇺🇸
Frontage Clinical Services, Inc., Secaucus, New Jersey, United States
News
No news found